Overuse of asthma inhalers may have unintended and potentially harmful effects in people with asthma. An article titled “Pharmacists Urged to Alert Physicians to Asthma Inhaler Overuse” published in Family Practice News (April 15, 1993; p. 46) raised early concerns about this issue and emphasized the role pharmacists can play in patient safety.
According to representatives from the National Asthma Education Program cited in the article, excessive reliance on short-acting rescue inhalers is associated with increased asthma mortality. Monitoring inhaler refill frequency was identified as a practical way to identify patients at higher risk. The authors suggested that if inhaler overuse were routinely reported to physicians, asthma-related deaths could potentially be reduced and overall treatment costs lowered.
Under typical use, a standard rescue inhaler is expected to last approximately 30 days. Patients who require replacement inhalers more frequently than this may have poorly controlled asthma rather than simply “bad lungs.” In such cases, inhaler overuse may serve as a warning sign that underlying airway inflammation or other contributing factors are not being adequately addressed.
This information highlights the importance of recognizing inhaler overuse as a marker of disease severity or poor control, rather than viewing increased inhaler use as a solution in itself.
This article is for educational purposes only and is not intended as medical advice.
